Rifampicin
Showing 1 - 25 of 481
Tuberculosis, Pulmonary Trial (Optimised dose rifampicin, Standard dose rifampicin)
Not yet recruiting
- Tuberculosis, Pulmonary
- Optimised dose rifampicin
- Standard dose rifampicin
- (no location specified)
Sep 26, 2023
Drug Interactions Trial in Gyeonggi-do (Methotrexate Sodium, Rifampicin)
Enrolling by invitation
- Drug Interactions
- Methotrexate Sodium
- Rifampicin
-
Gyeonggi-do, Korea, Republic ofSeoul National University Bundang Hospital
Oct 25, 2023
Healthy Trial (DA-8010 5mg, Clarithromycin 500mg, Rifampicin 600mg)
Not yet recruiting
- Healthy
- DA-8010 5mg
- +2 more
- (no location specified)
Aug 11, 2023
Healthy Subjects Trial in Shanghai (Part A ABSK201 and Itraconazole, Part A ABSK201 and Rifampicin)
Enrolling by invitation
- Healthy Subjects
- Part A ABSK201 and Itraconazole
- Part A ABSK201 and Rifampicin
-
Shanghai, Shanghai, ChinaHuashan Hospital Fudan University
Oct 12, 2023
Multiple Sclerosis Trial in Saint Paul (Tolebrutinib, gemfibrozil, rifampicin)
Completed
- Multiple Sclerosis
- Tolebrutinib
- +2 more
-
Saint Paul, MinnesotaPrism Research-Site Number:8400001
Sep 26, 2023
Healthy Volunteers Trial in Jinan (Cohort 1: SIM0417/ritonavir and itraconazole, Cohort 2: SIM0417/ritonavir and rifampicin,
Active, not recruiting
- Healthy Volunteers
- Cohort 1: SIM0417/ritonavir and itraconazole
- +2 more
-
Jinan, Shandong, ChinaShandong First Medical University
Jan 13, 2023
Locally Advanced or Metastatic NSCLC Trial in Nanjing (Rifampicin; ASK120067, ASK120067;itraconazole)
Completed
- Locally Advanced or Metastatic NSCLC
- Rifampicin; ASK120067
- ASK120067;itraconazole
-
Nanjing, Jiangsu, ChinaDrum Tower Hospital of Nanjing University School of Medical
Nov 20, 2022
Erectile Dysfunction Trial in Shanghai (TPN171H, Itraconazole, Rifampicin)
Completed
- Erectile Dysfunction
- TPN171H
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
Oct 17, 2023
Infections Joint Prosthetic Trial in France (amoxicillin or moxifloxacin, amoxicillin or moxifloxacin + rifampicin)
Not yet recruiting
- Infections Joint Prosthetic
- amoxicillin or moxifloxacin
- amoxicillin or moxifloxacin + rifampicin
-
Annecy, France
- +11 more
Jun 5, 2023
Drug Interaction Trial in Seoul (Methotrexate Sodium, Rifampicin Sodium, Febuxostat Tablets)
Completed
- Drug Interaction
- Methotrexate Sodium
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Bundang Hospital
Oct 10, 2022
Rifampicin-resistant Tuberculosis Trial in Beijing (Sudapyridine, Bedaquiline)
Enrolling by invitation
- Rifampicin-resistant Tuberculosis
-
Beijing, Beijing, ChinaBeijing Chest Hospital affiliated to Capital Medical University
Apr 21, 2023
Latent Tuberculosis, Staphylococcus Aureus Trial in Malmö (No intervention is part of the study protocol)
Recruiting
- Latent Tuberculosis
- Staphylococcus Aureus
- No intervention is part of the study protocol
-
Malmö, SwedenSkåne University Hospital
Oct 24, 2022
Tuberculous Meningitis Trial in Worldwide (Rifampicin (RIF), Isoniazid (INH), Linezolid (LZD))
Not yet recruiting
- Tuberculous Meningitis
- Rifampicin (RIF)
- +6 more
-
Porto Alegre, Brazil
- +9 more
Dec 14, 2022
Leprosy Trial in Moroni (BE-PEP Bedaquiline, SDR-PEP Rifampicin, BE-PEP Rifampicin)
Not yet recruiting
- Leprosy
- BE-PEP Bedaquiline
- +2 more
-
Moroni, ComorosFondation Damien
Oct 24, 2022
Dose Optimization of Rivaroxaban Combined With Rifampicin
Recruiting
- Infections
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Dec 17, 2022
Tuberculous Meningitis Trial in Chennai (High dose rifampicin (25mg/kg), Moxifloxacin 400mg, Aspirin 150 mg)
Not yet recruiting
- Tuberculous Meningitis
- High dose rifampicin (25mg/kg)
- +8 more
-
Chennai, Tamil Nadu, IndiaICMR- National Institute for Research in Tuberculosis
Jun 15, 2023
Diabetes Trial in Gieres (Sotagliflozin (SAR439954), Rifampicin)
Completed
- Diabetes Mellitus
- Sotagliflozin (SAR439954)
- Rifampicin
-
Gieres, FranceInvestigational Site Number 250001
Apr 21, 2022
Pulmonary Tuberculosis Trial in Cape Town (Meropenem 6g IV over 6 hours, Ertapenem 1g IM, Meropenem 3g IV)
Completed
- Pulmonary Tuberculosis
- Meropenem 6g IV over 6 hours
- +9 more
-
Cape Town, Western Cape, South AfricaTASK Clinical Research Centre
May 31, 2023
Drug-drug Interaction, Autoimmune Diseases, Fibrotic Disease Trial in Ruddington (Belumosudil, Itraconazole, Rabeprazole)
Completed
- Drug-drug Interaction
- +2 more
- Belumosudil
- +4 more
-
Ruddington, Nottingham, United KingdomQuotient Sciences Ltd
May 9, 2022
Type 2 Diabetes Trial in Jilin (Rongliflozin, Rifampin, Probenecid)
Completed
- Type 2 Diabetes Mellitus
- Rongliflozin
- +2 more
-
Jilin, Changchun, ChinaThe First Hospital of Jilin University
Aug 9, 2022
Tuberculosis, Human Immunodeficiency Virus Trial (Optimised rifamycin)
Not yet recruiting
- Tuberculosis
- Human Immunodeficiency Virus
- Optimised rifamycin
- (no location specified)
Oct 8, 2022
Solid Tumor Trial in Beijing (AB-106, Itraconazole, AB-106, Rifampicin)
Completed
- Solid Tumor
- AB-106, Itraconazole
- AB-106, Rifampicin
-
Beijing, ChinaXuanwu Hospital of Capital Medical University
Apr 27, 2022
Tuberculosis, Rifampicin Resistant Tuberculosis Trial in Worldwide (Pretomanid, Optimized background regimen (OBR) for
Not yet recruiting
- Tuberculosis
- Rifampicin Resistant Tuberculosis
- Pretomanid
- Optimized background regimen (OBR) for multidrug-resistant TB (MDR-TB
-
Rio De Janeiro, Brazil
- +6 more
Oct 18, 2022